Molecular Vision 2026; 32:410-419
<http://www.molvis.org/molvis/v32/410>
Received 05 November 2025 |
Accepted 14 September 2026 |
Published 20 September 2026
Anshuman Verma,1 Sneha Pranahitha Gorenka,1 Sunita Chaurasia,1,2,3 Deepak P. Edward,4 Muralidhar Ramappa1,2,3
1Institute for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, India; 2Cornea Institute, L V Prasad Eye Institute, Hyderabad, India; 3Jasti V Ramanamma Children's Eye Care Center, L V Prasad Eye Institute, Hyderabad, India; 4Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
Correspondence to: Muralidhar Ramappa, Head, Institute for Rare Eye Diseases and Ocular Genetics. The Cornea Institute & Jasti V Ramanamma Children's Eye Care Center, L V Prasad Eye Institute, Hyderabad, Telangana, India; Phone: +91 40 681012623, FAX: +91 40 68108271; email: [email protected].
Purpose: Cornea plana (CP) is a rare congenital anterior segment anomaly characterized by markedly flat corneal curvature under the influence of the KERA gene variant. The present study aims to delineate the clinical phenotype and underlying KERA gene variants in Indian patients with CP and to expand the mutational and phenotypic landscape of this rare congenital corneal dystrophy.
Methods: A retrospective study was performed for seven pediatric patients diagnosed with CP between 2010 and 2024 at a tertiary eye care center in India. All patients underwent comprehensive ophthalmic examinations. Whole-exome sequencing was conducted in all probands to detect pathogenic variants, which were classified according to the American College of Medical Genetics and Genomics guidelines and further assessed using in silico predictive tools.
Results: All seven cases exhibited the hallmark features of autosomal recessive CP, including bilateral microcornea, markedly flattened corneas, stromal haze, high hyperopia, indistinct limbal zone, and shallow anterior chamber. Iris adhesions were observed in six of seven patients. Genetic analysis revealed that all six probands harbored distinct homozygous KERA variants: two novel frameshift variations, c.264_298del (p.Glu88Aspfs*14) and c.59_78delinsA (p.Ser20TyrfsTer57); two known stop-gain variations, c.937C>T (p.Arg313Ter) and c.835C>T (p.Arg279Ter); and two known missense variations, c.809C>T, (p.Ser270Leu) and c.528C>G (p.Asn176Lys). One family with CP demonstrated a pseudo-dominant inheritance pattern evident from multiple affected members history despite molecular confirmation of a homozygous KERA variant in the proband. Management included refractive correction, occlusion therapy for amblyopia, and selective anterior segment reconstruction, including pupilloplasty in one eye and synechiolysis in another case. Despite these interventions, visual outcomes remained limited.
Conclusions: This study expands the clinical and genetic spectrum of KERA-associated CP in an Indian cohort by identifying two novel variants and documenting a rare pseudo-dominant inheritance pattern. Visual outcomes were generally limited, likely attributable to delayed presentation and amblyopia secondary to uncorrected high hyperopia during the critical period of neuroplasticity. Early recognition, prompt refractive correction, and molecular confirmation are essential to optimize visual prognosis and enable appropriate genetic counseling.
Cornea plana (CP) is a rare congenital anterior segment anomaly characterized by markedly reduced corneal curvature, which leads to an abnormally flat corneal surface. This results in decreased refractive power (25–35 D compared to the physiologic range of 40–45 D) and frequently coexists with microcornea, shallow anterior chamber, and central or peripheral corneal opacification [1]. Clinically, CP may present in early childhood with severe hyperopia, esotropia, and reduced visual acuity. The corneal limbus is typically widened and hazy, and a prominent arcus lipoides may be observed. In CP, the overall corneal thickness is reduced, with the periphery thinner than the center, a reversal of the distribution of corneal thickness in normal eyes, resulting in optical and structural impairments [2].
CP can manifest as either an autosomal dominant (CNA1; OMIM 121400) or autosomal recessive trait (CNA2; OMIM 217300) [3]. While the dominant form tends to be mild and manageable with optical correction, the recessive variant presents with greater anatomic derangement and often requires surgical intervention. Severe forms of CNA2 may involve anterior segment dysgenesis, including iris hypoplasia, correctopia, posterior embryotoxon, iris adhesions, and iris strands arising from the iris collarette and inserted onto the posterior surface of the cornea. These manifestations may lead to complications such as corneal ectasia, glaucoma, cataracts, and amblyopia [4]. Notably, CP may phenotypically overlap with other congenital corneal opacities, such as peripheral sclerocornea, posterior amorphous corneal dystrophy, and connective tissue disorders, such as Ehlers-Danlos syndrome type VI, making its accurate diagnosis a clinical challenge [5,6]. Advanced diagnostics, such as corneal topography, anterior segment optical coherence tomography (AS-OCT), and genetic testing, are instrumental in confirming the diagnosis and distinguishing CP from other similar disorders.
Genetically, autosomal recessive CP (CNA2) is linked to pathogenic variants of the KERA gene located on chromosome 12q22 [7]. KERA is a member of the small leucine-rich proteoglycan family and encodes keratocan, a cornea-specific keratan sulfate proteoglycan that is essential for maintaining the structural organization and optical transparency of the corneal stroma [8]. Loss of function in KERA disrupts collagen fibril alignment and stromal architecture, resulting in a CP phenotype as demonstrated in KERA knockout mice [9].
Although KERA-associated CP has been well characterized in Finnish and Saudi populations, often due to founder effects and high rates of consanguinity, reports from other ethnic backgrounds remain limited [1,10]. Most reported KERA variants are confined to a small number of recurrent variations, and little is known about the genetic diversity of CP in non-European populations. Data from underrepresented regions, such as India, are crucial for expanding the current understanding of genotype–phenotype correlations and allelic heterogeneity in CP.
In this study, we present one of the larger case series of genetically confirmed CP reported from India to date. This study provides insights into the phenotypic variability, inheritance patterns, and mutational spectrum of CP in a previously underrepresented Indian population.
This retrospective study was conducted at the L V Prasad Eye Institute, Hyderabad, India, after approval from the institutional review board and in accordance with the Declaration of Helsinki. Medical records of pediatric patients diagnosed with CP between January 2010 and December 2024 were reviewed. Written informed consent for the use of clinical and genetic data was obtained from the parents or legal guardians at the time of registration.
Inclusion criteria comprised pediatric patients diagnosed with CP based on characteristic clinical findings, including microcornea, markedly flattened corneal curvature, corneal opacification or stromal haze, indistinct limbal architecture, and iris adhesions or shallow anterior chambers. Patients with isolated microcornea or nonspecific corneal haze without supportive clinical features, or those with incomplete ophthalmic or genetic records, were excluded. A total of seven cases, including six probands (CP1–CP6) and one affected sibling (CP5a), fulfilled the eligibility criteria and were included in the analysis.
Demographic and clinical data were extracted from electronic medical records. Variables recorded included age at presentation, sex, laterality, parental consanguinity, family history, and clinical presentation wherever available, such as visual acuity, refractive error, keratometry values, axial length, anterior segment findings, and intraocular pressure. All patients underwent ophthalmic examination, including slit-lamp biomicroscopy, cycloplegic retinoscopy, and dilated fundus examination when media clarity permitted. Anterior segment imaging was performed using AS-OCT or ultrasound biomicroscopy (UBM) to assess corneal thickness, anterior chamber depth, angle configuration, and iris insertion. AS-OCT was performed in CP1, CP5, and CP5a, whereas UBM was performed in the remaining cases. Corneal endothelial specular microscopy was performed in CP5a.
Whole-exome sequencing was performed in all probands (CP1–CP6) at a certified molecular diagnostics laboratory (Redcliffe Labs, Hyderabad, India) to identify pathogenic variants in KERA. Exome capture targeted approximately 99% of protein-coding regions (CCDS and RefSeq databases). Sequencing was performed on the Illumina NovaSeq platform (San Diego, CA, USA) with an average coverage depth of 100–150×; >90% of targeted regions achieved ≥30× coverage. Variant calling was performed using the Genome Analysis Toolkit, and annotation was conducted using Golden Helix VarSeq and VarSome pipelines. Variants were interpreted according to the American College of Medical Genetics and Genomics guidelines, as provided in the laboratory report.
Pathogenicity of identified variants was evaluated using multiple in silico prediction tools. Variant annotation and functional prediction were performed using Ensembl Variant Effect Predictor (VEP) and MutationTaster. Functional impact was further assessed using SIFT, PolyPhen-2, and combined annotation-dependent depletion (https://cadd.gs.washington.edu/) scores. Predictions of nonsense-mediated mRNA decay were also analyzed. Evolutionary conservation of altered amino acid residues was assessed across orthologous species using multiple sequence alignment with Clustal Omega. A homology-based three-dimensional model of the wild-type (WT) human KERA protein was generated using MODELER, employing the crystal structure of the fused N-terminal domains of Internalin B (PDB ID: 1H6T) as the template. Mutant protein models (p.Asn176Lys and p.Ser270Leu) were generated based on the WT structure. Structural superimposition and root mean square deviation analysis were performed using UCSF Chimera. Changes in protein stability (ΔΔG) between WT and mutant proteins were estimated using DDMut.
Seven children (four males, three females) with clinically diagnosed CP were included. The mean age at presentation was 1.9 years. Bilateral involvement was observed in all cases. Parental consanguinity was documented in five of six families (83%). A positive family history was present in one family (CP5), in which the sibling (CP5a) exhibited a similar phenotype (Figure 1). Presenting visual acuity was markedly reduced, ranging from fix-and-follow behavior in infants (CP2, CP3, and CP6) to measurable acuity in a ranging from 6/36 to 6/201 in older children (CP1, CP4, CP5, CP5a). High hyperopia (+9.5 to +14.0 D) was observed in all patients. Intraocular pressure was within normal limits in all except CP1, who had elevated pressures (25–26 mm Hg). Slit-lamp examination revealed microcornea, markedly flattened corneal curvature, indistinct limbal architecture, and central or diffuse stromal haze in all cases. Anterior segment imaging (AS-OCT/UBM) consistently demonstrated anterior iris insertion in all except one (CP4), and all eyes exhibited shallow anterior chambers (Table 1). The representative images of ocular presentation are shown in Figure 2 and Figure 3 for CP1 and CP5a, respectively. Fundus evaluation (image not shown) was feasible in four cases (CP1, CP3, CP4, CP6); optic discs were normal in three, whereas CP1 showed glaucomatous cupping consistent with secondary glaucoma. Visualization was not possible in other cases due to dense corneal haze, obliterated pupils, or noncooperation.
Given the late presentation and absence of prior adequate visual rehabilitation, dense amblyopia was already established in these patients. Therefore, all patients received high-plus refractive correction and occlusion therapy. Surgical intervention was required in two patients: pupilloplasty in one eye of CP1 and synechiolysis in CP3. The surgical interventions in CP1 were primarily performed to enlarge the pupillary aperture to facilitate accurate refraction and fundus visualization and in CP3 to reduce the risk of secondary developmental glaucoma. CP1 also required topical antiglaucoma medication owing to glaucomatous features. Eyes undergoing surgical intervention (in CP1 and CP3) demonstrated modest visual improvement, with gains of up to one Snellen line from baseline acuity. Patients managed conservatively (CP2, CP4–CP7) with early optical correction maintained functional visual acuity ranging from 6/9 to 6/240 at final follow-up (Table 1).
Homozygous KERA variants (NM_007035.4) were identified in all six probands (Table 2). Two novel frameshift variants were detected: c.264_298del (p.Glu88Aspfs*14) in CP1 and c.59_78delinsA (p.Ser20TyrfsTer57) in CP2. CP3 harbored a missense variant, c.809C>T (p.Ser270Leu); CP4 carried a stop-gain (nonsense) variant, c.937C>T (p.Arg313Ter); CP5 exhibited a missense variant, c.528C>G (p.Asn176Lys); and CP6 carried a stop-gain variant, c.835C>T (p.Arg279Ter)—all documented previously in CP. The CP5 pedigree suggested pseudo-dominant inheritance due to multiple affected individuals across generations despite an underlying autosomal recessive genotype (Figure 1).
In silico analysis supported pathogenicity for most identified variants (Table 2). The frameshift variants were predicted to result in premature truncation with likely nonsense-mediated decay. The Mutation Taster identified all variants to be deleterious. The nonsense variants p.Arg313Ter and p.Arg279Ter were predicted to escape nonsense-mediated decay, potentially producing truncated proteins. The missense variants (p.Ser270Leu and p.Asn176Lys) were predicted to be deleterious by SIFT, PolyPhen-2, and combined annotation-dependent depletion. Conservation analysis demonstrated strong evolutionary conservation at the Asn176 and Ser270 positions (Figure 4). Structural modeling of mutant proteins (p.Asn176Lys and p.Ser270Leu) (Figure 5B) revealed minimal global conformational deviation between wild-type and mutant proteins (root mean square deviation 0.188 Å and 0.204 Å, respectively). However, stability analysis predicted destabilization (mutation cutoff scanning matrix [mCSM] ΔΔG −0.16 kcal/mol; site-directed mutator [SDM] ΔΔG −1.33 kcal/mol), suggesting functional impairment despite preservation of overall protein folding.
This study reports six genetically confirmed cases of CP of Indian origin, each harboring homozygous pathogenic or likely pathogenic variants of the KERA gene. Our findings not only confirm the clinical diagnosis but also expand the known mutational spectrum associated with CP. Although CP has been historically reported in populations from Finland, Cuba, and Saudi Arabia, data from ethnically diverse groups remain limited [1,10,11]. To the best of our knowledge, this study presents one of the most extensive clinically and genetically characterized series of CP cases from India, contributing to a better understanding of its phenotypic variability and genetic diversity.
All patients in our cohort presented with the features of CP, including bilateral microcornea, markedly flattened corneal curvature, and stromal opacification involving the visual axis. Associated anterior segment findings, such as iris adhesions, anterior chamber shallowing, and pupillary displacement, were observed. These structural abnormalities frequently lead to profound visual impairment, ranging from fix-and-follow behavior to severe amblyopia and high hyperopia. Published literature offers limited documentation of iris adhesions in CP. Bruni et al. [12] described a single case demonstrating iris synechiae using laser-scanning in vivo confocal microscopy in recessive CP. In contrast, our study used both AS-OCT and UBM to comprehensively assess the anterior chamber, including iris insertion. AS-OCT allowed precise quantification of severe corneal flattening, pachymetry, and markedly shallow anterior chamber depth, as well as evaluation of the iris–cornea relationship. On the other hand, UBM showed a detailed visualization of anterior chamber configuration, angle anatomy, and ciliary body position, detecting anterior rotation, lens displacement, and structural risk factors for angle closure. Both provided a complete picture for diagnosis and glaucoma risk assessment in CP [13]. Additional complications, including elevated intraocular pressure secondary glaucoma, endothelial decompensation, and cataract formation, have been reported in some cases, emphasizing the progressive nature and multisystemic impact of the disease within the eye [14-17]. However, the corneal endothelium, analyzed in one case (CP5a) in our study, had a normal morphology (Figure 3).
Among the six identified KERA variants, two were novel and had not been previously reported in patients with CP. Among the reported variants, the p.Arg313Ter variant is considered a recurrent stop-gain mutation [10,17,18], and p.Arg279Ter has been described in multiple studies [2,7,10,16,19]. The variants p.Ser270Leu and p.Asn176Lys were identified in a UK-based multiethnic cohort from the 100,000 Genomes Project, in which two patients with the CP phenotype harbored these variants [20]. Pellegata et al. [7] found 46 Finnish patients homozygous for a single founder missense KERA mutation, c.740A>G (p.Asn247Ser). In a cohort of five CP cases from Czech and Turkish populations, Czech probands carried either compound heterozygous variants (c.209C>T; p.(Pro70Leu); c.887–1G>A) or the recurrent homozygous nonsense variant c.835C>T (p.Arg279*), while Turkish probands had homozygous missense variants c.740A>G (p.Asn247Ser) or c.674C>T (p.Ile225Thr), with c.740A>G being the most recurrent KERA mutation across populations [19]. Importantly, our genetic findings highlight the considerable allelic heterogeneity of KERA. All cases had different KERA variants localized to different exonic regions of the KERA gene, suggesting that pathogenic alterations across multiple domains can disrupt corneal morphogenesis (Figure 5A).
Notably, in the CP5 pedigree, the clinical history initially suggested an autosomal dominant pattern of inheritance owing to multiple affected members. However, genetic analysis revealed that the proband harbored a homozygous KERA variant c.528C>G (p.Asn176Lys), indicating an autosomal recessive form of CP. The corresponding clinical phenotypes were also consistent with those of autosomal recessive CP. This observation raises the possibility of pseudo-dominant inheritance in this family, a pattern that, to our knowledge, has not been previously reported in CP. Nonetheless, a comprehensive segregation analysis involving both affected and unaffected family members is required to substantiate this hypothesis. Collectively, these findings expand the clinical and allelic spectrum of KERA-associated CP.
Given the genetic basis and early-onset nature of CP, genetic testing should be considered integral to the diagnostic workup, particularly in patients with atypical anterior segment features or in populations with a high prevalence of consanguineous marriages. Molecular confirmation not only aids in diagnosis but also provides a basis for genetic counseling and reproductive planning, especially in families with multiple affected individuals. Furthermore, improved characterization of variant pathogenicity through large-scale registries and functional validation may refine our prognostic understanding and identify potential therapeutic targets.
Management plans in CP remain largely supportive, with primary emphasis on optimal refractive correction. Surgical interventions may be considered in selected cases with residual refractive error, including photorefractive keratectomy and laser thermal keratoplasty, laser in situ keratomileusis, or conductive keratoplasty. While surgical interventions may provide limited benefit in selected cases, their overall role remains restricted due to the underlying structural abnormalities of the cornea and variable visual outcomes [21]. In our cohort, treatment strategies included hyperopic refractive correction, amblyopia therapy, and selective anterior segment reconstruction. The surgical interventions were performed primarily for visual rehabilitation and prevention of complications. Refractive correction with glasses or contact lenses is often challenging due to extreme hyperopia and corneal irregularities. Additionally, lenticular changes such as cataracts require individualized surgical planning, with intraocular lens selection carefully tailored to the unique anterior segment anatomy and refractive needs [22]. In cases of dense central corneal opacities, surgical interventions such as corneal transplantation remain inadequately established in CP. The outcomes of keratoplasty are often limited by underlying anatomic challenges, including reduced corneal thickness, shallow anterior chamber depth, and significant irregular astigmatism, which collectively compromise graft success and visual rehabilitation [23]. These challenges underscore the importance of early diagnosis and multidisciplinary management to optimize visual outcomes.
Overall, this study broadens the clinical and genetic landscape of KERA-associated CP in an Indian cohort. A key limitation of this study is that the identified variants were not validated by Sanger sequencing but were instead inferred from whole-exome sequencing reports and phenotypic concordance. However, identifying two novel KERA variants and one instance of pseudo-dominant inheritance highlights the importance of a comprehensive genetic evaluation. These findings underscore the value of early genetic testing and detailed ophthalmic evaluation in guiding patient management. Given the lack of effective treatments, further research is warranted to explore targeted therapeutic options.
We would like to acknowledge patients and their families for their participation and Hyderabad Eye Research Foundation (HERF) and Hyderabad Eye Institute (HEI) for institutional funding support. Conflict of interests: The authors declare that there is no conflict of interest. Financial support: Hyderabad Eye Research Foundation and Hyderabad Eye Institute, Hyderabad, India. Financial Disclosure (s): The authors have no proprietary or commercial interest in any materials discussed in this article. Author’s Role: Involved in the design and conduct of the study (MDR); data collection (AV, SPG, MDR); analysis and interpretation of results (AV, MDR, SCH, DE); preparation of the manuscript and literature search (AV, MDR, SPG, DE); review of the manuscript (AV, MDR, DE); final approval (MDR).
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. CC BY-NC-ND includes the following elements: BY: credit must be given to the creator. NC: Only noncommercial uses of the work are permitted. ND: No derivatives or adaptations of the work are permitted.